Survey: Did the FDA Jump the Gun?
Take this MedPage Today survey.
The FDA announced yesterday that studies of two prescription proton-pump inhibitors, omeprazole (Prilosec) and esomeprazole (Nexium), had raised concerns about their cardiovascular safety. In the same announcement, the agency said its preliminary assessment was that the problems seen in those studies were "not a true effect." But a final safety report remained three months away.
Recent Videos
Impressions From Case 2
The "Ugly Face" of Long COVID: A Conversation with Steven Flanagan, MD, President-elect, AAPM&R
Persistent Vaccine Skepticism Can Erode Clinician Confidence in their Own Recommendations
"Vaccination is More of a Marathon than a Sprint, so Keep Listening”
Factors to Consider When Treating Acute Pain
Diagnosis of Acute Pain
Booster Fatigue, Vaccines are for Kids, and Other Obstacles to Adult Immunization in Primary Care
Vaccine Hesitancy: How COVID-19 Changed the Tone, with Gretchen LaSalle, MD
Impact of COVID-19 on Acute Pain Management
Pathogenesis and Causes of Acute Pain
